None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who voluntarily provide written informed consent to participate in the study Patients aged 65 years or older at the time of surgery Patients scheduled to undergo laparoscopic cholecystectomy under general anesthesia Patients classified as American Society of Anesthesiologists (ASA) physical status I–III Patients considered appropriate for study participation by the investigator
Exclusion criteria
Exclusion criteria: Patients scheduled for open cholecystectomy or converted to open surgery during the procedure Patients with severe cardiovascular disease that may affect study intervention or outcome assessment (e.g., left ventricular ejection fraction <30% or heart failure of NYHA class III or higher) Patients with a body mass index (BMI) greater than 35 kg/m² Patients with severe hepatic or renal dysfunction Patients with severe cognitive impairment, communication difficulty, or inability to cooperate with study procedures Patients with a contraindication or known hypersensitivity to propofol, remifentanil, or other study-related medications Patients with chronic opioid use before surgery or a history of drug or alcohol abuse Patients considered inappropriate for study participation by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure stability (defined as the proportion of total anesthesia time during which intraoperative mean arterial pressure [MAP] remains within ±20% of the preoperative baseline MAP) | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of intraoperative hypertensive/ hypotensive episodes;Duration of hypertensive episodes and total dose of antihypertensive agents used during hypertensive episodes;Duration of hypotensive episodes and total dose of vasopressors used during hypotensive episodes;Time from discontinuation of anesthetic administration to extubation | — |
Countries
Korea, Republic of
Contacts
Ewha Womans University Seoul Hospital